Clinical Trial Update: Senolytics to Improve Osteoporosis Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating senolytics to enhance osteoporosis therapy; current status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Bone Loss
• Osteopenia
• Osteoporosis

Snippet

Sponsor: Odense University Hospital | Conditions: Osteopenia, Osteoporosis, Age-related Bone Loss | Phase 2 | Status: ACTIVE_NOT_RECRUITING